semaglutide weight loss medication Novo Nordisk's weight-loss pill wins FDA approval What to Know About Semaglutide:

The two GHRH analogs differ mainly on kinetics (sermorelin = natural structure, short half-life, daily

In the warning letter, FDA includes several repeat observations from 2022, including discoloration on equipment in the ISO 5 area, monitoring environmental conditions in aseptic processing areas, and failure to establish and follow appropriate written procedures to prevent microbiological contamination

A Phase III, Multicentre, Randomised, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutanenous Bioresorbable CUV1647 Implants in Patients With Erythropoietic Protoporphyria (EPP) (Report)

569, no